Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$27,000.00
Metabolic Adaptation to weight loss in Response to a behavioural lifestyle program with or without semaglutide in adolescents with obesity
EF 2024-25
Résumé
In Canada, obesity affects one in three youth, increasing their risk for type 2 diabetes, cardiovascular disease, and cancer. While diet and physical activity are primary treatments, long-term weight loss is often unsustainable due to adaptive thermogenesis (AT);a decrease in EE that exceeds expected changes in body mass. Glucagon-like peptide-1 agonists, like semaglutide, have emerged as adjacent therapies to promote weight loss. Additionally, muscle work efficiency is often reduced in individuals with obesity and linked to poorer metabolic health. Weight loss is associated with improved work efficiency, thus contributing to AT through decreased energy use during physical activity. This study examines EE and work efficiency in 74 adolescents with obesity enrolled in a behavioral lifestyle program (BLP). Participants will be randomized into two groups: Group A will follow BLP for 6 months, then combine BLP with semaglutide for 6 months. Group B will begin with BLP and semaglutide for 6 months, then complete the study. EE will be assessed using whole room calorimetry, and work efficiency will be measured using cycle ergometry during standardized exercise. The study aims to 1) Measure changes in EE, and AT at 6 and 12 months in response to semaglutide the above population and 2) Examine if semaglutide reduces the decline in work efficiency during standardized exercise. It is hypothesized that semaglutide will result in less decline in EE compared to BLP and work efficiency will increase. AT is well recognized in adults, but it is unclear if it occurs in pediatrics, thus this research is important to address the gaps in AT research. By exploring pharmacotherapeutic effects on EE, clinicians can use this information to examine AT changes between weight interventions.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
529729
Name
Flores Miranda Athena E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Metabolic Adaptation to weight loss in Response to a behavioural lifestyle program with or without semaglutide in adolescents with obesity
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adaptive Thermogenesis; Diabetes; Energy Expenditure; Glp-1 Agonists; Metabolism; Obestiy; Pediatrics; Semaglutide; Weight Loss; Whole Room Calorimetry
Abstract
In Canada, obesity affects one in three youth, increasing their risk for type 2 diabetes, cardiovascular disease, and cancer. While diet and physical activity are primary treatments, long-term weight loss is often unsustainable due to adaptive thermogenesis (AT);a decrease in EE that exceeds expected changes in body mass. Glucagon-like peptide-1 agonists, like semaglutide, have emerged as adjacent therapies to promote weight loss. Additionally, muscle work efficiency is often reduced in individuals with obesity and linked to poorer metabolic health. Weight loss is associated with improved work efficiency, thus contributing to AT through decreased energy use during physical activity. This study examines EE and work efficiency in 74 adolescents with obesity enrolled in a behavioral lifestyle program (BLP). Participants will be randomized into two groups: Group A will follow BLP for 6 months, then combine BLP with semaglutide for 6 months. Group B will begin with BLP and semaglutide for 6 months, then complete the study. EE will be assessed using whole room calorimetry, and work efficiency will be measured using cycle ergometry during standardized exercise. The study aims to 1) Measure changes in EE, and AT at 6 and 12 months in response to semaglutide the above population and 2) Examine if semaglutide reduces the decline in work efficiency during standardized exercise. It is hypothesized that semaglutide will result in less decline in EE compared to BLP and work efficiency will increase. AT is well recognized in adults, but it is unclear if it occurs in pediatrics, thus this research is important to address the gaps in AT research. By exploring pharmacotherapeutic effects on EE, clinicians can use this information to examine AT changes between weight interventions.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Flores Miranda, Athena E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~